Correlation Between Upstream Bio, and Silo Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Upstream Bio, and Silo Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Upstream Bio, and Silo Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Upstream Bio, and Silo Pharma, you can compare the effects of market volatilities on Upstream Bio, and Silo Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Upstream Bio, with a short position of Silo Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Upstream Bio, and Silo Pharma.

Diversification Opportunities for Upstream Bio, and Silo Pharma

-0.67
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Upstream and Silo is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Upstream Bio, and Silo Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Silo Pharma and Upstream Bio, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Upstream Bio, are associated (or correlated) with Silo Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Silo Pharma has no effect on the direction of Upstream Bio, i.e., Upstream Bio, and Silo Pharma go up and down completely randomly.

Pair Corralation between Upstream Bio, and Silo Pharma

Considering the 90-day investment horizon Upstream Bio, is expected to under-perform the Silo Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Upstream Bio, is 1.2 times less risky than Silo Pharma. The stock trades about -0.05 of its potential returns per unit of risk. The Silo Pharma is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  286.00  in Silo Pharma on November 2, 2024 and sell it today you would lose (103.00) from holding Silo Pharma or give up 36.01% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy15.59%
ValuesDaily Returns

Upstream Bio,  vs.  Silo Pharma

 Performance 
       Timeline  
Upstream Bio, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Upstream Bio, has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Silo Pharma 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Silo Pharma are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very abnormal essential indicators, Silo Pharma displayed solid returns over the last few months and may actually be approaching a breakup point.

Upstream Bio, and Silo Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Upstream Bio, and Silo Pharma

The main advantage of trading using opposite Upstream Bio, and Silo Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Upstream Bio, position performs unexpectedly, Silo Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Silo Pharma will offset losses from the drop in Silo Pharma's long position.
The idea behind Upstream Bio, and Silo Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets